Advertisement

Topics

CYTOVIA Inc, IMMUNE Pharma’s Oncology Subsidiary, Announces Publication of Results Showing ...

05:06 EDT 9 Aug 2017 | BioMedReports - Blog
Additional potential in cancer immunotherapy with Ceplene in combination with Interleukin-15 (IL-15)

Read more...

Original Article: CYTOVIA Inc, IMMUNE Pharma’s Oncology Subsidiary, Announces Publication of Results Showing ...

NEXT ARTICLE

More From BioPortfolio on "CYTOVIA Inc, IMMUNE Pharma’s Oncology Subsidiary, Announces Publication of Results Showing ..."

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...